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Introduction
Carcinoma of the uterine cervix is a common gynecologic
malignant neoplasm all over the world. The most common histological
type of malignant cervical neoplasms is squamous cell carcinoma [1,2].
Clear cell adenocarcinomas (CCAC) of the uterine cervix is a rare
disease accounting for only 4% of all adenocarcinomas of the uterine
cervix [3]. Primary CCAC of the uterine cervix is a rare neoplastic
entity which occurs in young women exposed to DES in utero; primary
CCAC without DES exposure in utero is extremely rare. Here we
report a 23- years-old Spanish female with primary CCA of the uterine
cervix with no maternal history of DES ingestion during pregnancy.
Case Report
A 23-year-old woman, nulligravida, without any coexisting disease,
with negative familiar cancer history, presented irregular vaginal
bleeding for last two months, sometimes as a menstruation and others
as a spotting. Routine gynecological screening were normal (the last
one was a year ago).
Figure 1: Tumoral proliferation of tubular, glandular and papillary
pattern with clear cell of large and eosinophilic cytoplasm and
atypical large nucleus.
Exposure to DES was denied. Gynecological examination revealed
cervical polypoid lesion of 3 x 0.5 cm. The patient underwent surgery
for a cervical conization. Histopathological examination showed
papilar and tubular proliferations and clear cell adenocarcinoma
(Figures 1 and 2). All other biochemical, hematological and
radiological tests were within normal limits. Contrast-enhanced
computed tomographic scan did not reveal any suggestive lesion of
malignancy. The patient was therefore diagnosed as a case of CCAC of
cervix, FIGO stage IBI. She underwent radical trachelectomy of cervix
(Figures 3 and 4) with bilateral pelvic lymph node dissection and both
interiliac sentinel node. Sentinel node intraoperative results were
negative. Histologically results were negative and there was no residual
tumor at the cervix. FIGO stage IBI was confirmed. 18 months after
the surgery, no signs of recurrence have been detected.
Figure 2: Tumoral proliferation of tubular, glandular and papillary
pattern with clear cell of large and eosinophilic cytoplasm and
atypical large nucleus.
Figure 3: Ureter dissection during vaginal trachelectomy.
Discussion
Most cancers of the uterine cervix are squamous cell carcinomas,
but the incidence of adenocarcinoma is rising in recent years and
adenocarcinoma now accounts for about 20% of incidental invasive
cervical cancers in screened populations worldwide [3,4]. CCAC of the
cervix is a rare tumor accounting for only 4% of all adenocarcinomas
of the uterine cervix.
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Figure 4: Final vaginal view.
There were an increased incidence between 1970-1980 of CCAC
and a causal association was established with DES exposure. DES was
used to reduce the complications of pregnancy like toxaemia (bleeding,
premature birth and neonatal death) [5]. Median age of DES related
clear cell carcinoma is 18.9 years. Primary clear cell carcinoma without
any previous history of DES exposure is an extremely rare neoplasm.
Median age of clear cell carcinoma non- associated with DES exposure
is 53 years and it commonly presents with irregular vaginal bleeding
(80%) [6].
The absence of specific symptoms, as in our patient, makes the
diagnosis more difficult. The current diagnostic methods could be less
effective. These factors together could delay the correct diagnosis and
worsen the prognosis for patients [2,7].
Surgical resection is important for survival. Although radiotherapy
is commonly used instead of surgery to treat adults with cervical
cancer, surgery should be considered the treatment of choice for
children or young adolescents due to the risk of radiation brosis of the
bladder and bowel loop [8]. Carboplatin and paclitaxel regimens have
comparable response rates for the treatment of advanced
adenocarcinoma of the cervix without toxicity [9].
The selection criteria for radical trachelectomy are a desire for
pregnancy, confirmed diagnosis of cervical cancer (any histological
type except for neuroendocrine tumour and sarcoma), tumour size
equal to or less than 2 cm, less than 50% stromal invasion, FIGO stage
IA1 with LVI, IA2 or IB1, absence of any evidence of metastasis in or
away from the pelvic lymph nodes, and age under 40 years [10,11].
Dargent et al. [12] first described “fertility sparing” trachelectomy
for women with cervical cancers less than 2 cm [12]. Our patient is in
her reproductive years so conservative management of early-stage
cervical carcinoma is the best option. Recurrence and death rates
(4.2% and 2.8%, respectively) of radical vaginal trachelectomy (RVT)
seem to be comparable to classical radical abdominal hysterectomy. It
appears that RVT's overall recurrence and death rates were similar to
early-stage cervical cancer treated by radical hysterectomy or
radiotherapy. Furthermore fertility results of RVT seem to be
promising. A 70% pregnancy rate was reported in the women who
wanted to conceive following RVT, though such patients should be
informed about the risk of second trimester loss and preterm delivery
[13-16].
In conclusion, in young patients with early stages CCAC of the
cérvix without risk factors a fertility sparing approach could be
considered as one of the options of treatment.
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